Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 220

Similar articles for PubMed (Select 20395859)

1.

Factors predicting response and survival after yttrium-90 radioembolization of unresectable neuroendocrine tumor liver metastases: a critical appraisal of 48 cases.

Saxena A, Chua TC, Bester L, Kokandi A, Morris DL.

Ann Surg. 2010 May;251(5):910-6. doi: 10.1097/SLA.0b013e3181d3d24a.

PMID:
20395859
2.

Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.

Hoffmann RT, Paprottka PM, Schön A, Bamberg F, Haug A, Dürr EM, Rauch B, Trumm CT, Jakobs TF, Helmberger TK, Reiser MF, Kolligs FT.

Cardiovasc Intervent Radiol. 2012 Feb;35(1):105-16. doi: 10.1007/s00270-011-0142-x. Epub 2011 Mar 24.

PMID:
21431970
3.

Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option.

Saxena A, Bester L, Chua TC, Chu FC, Morris DL.

Ann Surg Oncol. 2010 Feb;17(2):484-91. doi: 10.1245/s10434-009-0777-x. Epub 2009 Oct 30.

PMID:
19876691
4.

Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases.

King J, Quinn R, Glenn DM, Janssen J, Tong D, Liaw W, Morris DL.

Cancer. 2008 Sep 1;113(5):921-9. doi: 10.1002/cncr.23685.

5.

Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.

Kennedy AS, Dezarn WA, McNeillie P, Coldwell D, Nutting C, Carter D, Murthy R, Rose S, Warner RR, Liu D, Palmedo H, Overton C, Jones B, Salem R.

Am J Clin Oncol. 2008 Jun;31(3):271-9. doi: 10.1097/COC.0b013e31815e4557.

PMID:
18525307
6.

Radioembolization in patients with hepatic metastases from breast cancer.

Jakobs TF, Hoffmann RT, Fischer T, Stemmler HJ, Tatsch K, La Fougere C, Murthy R, Reiser MF, Helmberger TK.

J Vasc Interv Radiol. 2008 May;19(5):683-90. doi: 10.1016/j.jvir.2008.01.009. Epub 2008 Mar 19.

PMID:
18440456
7.

90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience.

Rhee TK, Lewandowski RJ, Liu DM, Mulcahy MF, Takahashi G, Hansen PD, Benson AB 3rd, Kennedy AS, Omary RA, Salem R.

Ann Surg. 2008 Jun;247(6):1029-35. doi: 10.1097/SLA.0b013e3181728a45.

PMID:
18520231
8.

Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres.

Paprottka PM, Hoffmann RT, Haug A, Sommer WH, Raessler F, Trumm CG, Schmidt GP, Ashoori N, Reiser MF, Jakobs TF.

Cardiovasc Intervent Radiol. 2012 Apr;35(2):334-42. doi: 10.1007/s00270-011-0248-1. Epub 2011 Aug 17.

PMID:
21847708
9.

Yttrium-90 radioembolization for liver malignancies: prognostic factors associated with survival.

Dunfee BL, Riaz A, Lewandowski RJ, Ibrahim S, Mulcahy MF, Ryu RK, Atassi B, Sato KT, Newman S, Omary RA, Benson A 3rd, Salem R.

J Vasc Interv Radiol. 2010 Jan;21(1):90-5. doi: 10.1016/j.jvir.2009.09.011. Epub 2009 Nov 25.

PMID:
19939705
10.

Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases.

Cao CQ, Yan TD, Bester L, Liauw W, Morris DL.

Br J Surg. 2010 Apr;97(4):537-43. doi: 10.1002/bjs.6931.

PMID:
20205229
11.

Yttrium-90 radioembolization of renal cell carcinoma metastatic to the liver.

Abdelmaksoud MH, Louie JD, Hwang GL, Kothary N, Minor DR, Sze DY.

J Vasc Interv Radiol. 2012 Mar;23(3):323-30.e1. doi: 10.1016/j.jvir.2011.11.007. Epub 2012 Jan 25.

PMID:
22277275
12.

Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases.

Jakobs TF, Hoffmann RT, Dehm K, Trumm C, Stemmler HJ, Tatsch K, La Fougere C, Murthy R, Helmberger TK, Reiser MF.

J Vasc Interv Radiol. 2008 Aug;19(8):1187-95. doi: 10.1016/j.jvir.2008.05.013. Epub 2008 Jun 27.

PMID:
18656012
13.

Yttrium-90 radioembolization is a safe and effective treatment for unresectable hepatocellular carcinoma: a single centre experience of 45 consecutive patients.

Saxena A, Meteling B, Kapoor J, Golani S, Danta M, Morris DL, Bester L.

Int J Surg. 2014 Dec;12(12):1403-8. doi: 10.1016/j.ijsu.2014.07.269. Epub 2014 Aug 1.

PMID:
25091398
14.

Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization.

Murthy R, Kamat P, Nunez R, Madoff DC, Gupta S, Salem R, Yao JC.

J Vasc Interv Radiol. 2008 Jan;19(1):145-51. doi: 10.1016/j.jvir.2007.09.006.

PMID:
18192482
15.

Yttrium-90 radioembolization for unresectable, chemoresistant breast cancer liver metastases: a large single-center experience of 40 patients.

Saxena A, Kapoor J, Meteling B, Morris DL, Bester L.

Ann Surg Oncol. 2014 Apr;21(4):1296-303. doi: 10.1245/s10434-013-3436-1. Epub 2013 Dec 15.

PMID:
24337647
16.

A retrospective comparative analysis of the effect of Y90-radioembolization on the survival of patients with unresectable hepatocellular carcinoma.

D'Avola D, Lñarrairaegui M, Bilbao JI, Martinez-Cuesta A, Alegre F, Herrero JI, Quiroga J, Prieto J, Sangro B.

Hepatogastroenterology. 2009 Nov-Dec;56(96):1683-8.

PMID:
20214218
17.

90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival.

Bangash AK, Atassi B, Kaklamani V, Rhee TK, Yu M, Lewandowski RJ, Sato KT, Ryu RK, Gates VL, Newman S, Mandal R, Gradishar W, Omary RA, Salem R.

J Vasc Interv Radiol. 2007 May;18(5):621-8.

PMID:
17494843
18.

Radioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases.

Peker A, Çiçek O, Soydal Ç, Küçük NÖ, Bilgiç S.

Diagn Interv Radiol. 2015 Jan-Feb;21(1):54-9. doi: 10.5152/dir.2014.14036.

19.

Radioembolization versus standard care of hepatic metastases: comparative retrospective cohort study of survival outcomes and adverse events in salvage patients.

Bester L, Meteling B, Pocock N, Pavlakis N, Chua TC, Saxena A, Morris DL.

J Vasc Interv Radiol. 2012 Jan;23(1):96-105. doi: 10.1016/j.jvir.2011.09.028. Epub 2011 Nov 12.

PMID:
22079516
20.

Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes.

Memon K, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Sato KT, Gupta R, Nikolaidis P, Miller FH, Yaghmai V, Gates VL, Atassi B, Newman S, Omary RA, Benson AB 3rd, Salem R.

Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):887-94. doi: 10.1016/j.ijrobp.2011.07.041. Epub 2011 Dec 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk